| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000037784 |
| Receipt No. | R000043091 |
| Scientific Title | Evaluation of fatigue reduction by food containing CoQ10 and krill oil:a randomized, double blind, placebo-controlled study |
| Date of disclosure of the study information | 2019/09/13 |
| Last modified on | 2020/04/24 (Ver. 5) |
| Basic information | ||
| Public title | Evaluation of fatigue reduction by food containing CoQ10 and krill oil | |
| Acronym | CoQ10 trial | |
| Scientific Title | Evaluation of fatigue reduction by food containing CoQ10 and krill oil:a randomized, double blind, placebo-controlled study | |
| Scientific Title:Acronym | CoQ10 trial | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Compare the differences in fatigue levels between the test group, the control group, and the placebo group |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | instrument measurement, VAS, Chalder fatigue scale |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of test article daily for 12 weeks | |
| Interventions/Control_2 | Ingestion of cotrol article A daily for 12 weeks | |
| Interventions/Control_3 | Ingestion of cotrol article B daily for 12 weeks | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects who are tired | |||
| Key exclusion criteria | 1. Subject with a history of food allergy
2. Subject who are pregnant or nursing 3. Subjects taking health food that has effect 4. Subjects taking medication to bring about the effect 5. Subjects with frail constitution, Subjects with chronic fatigue |
|||
| Target sample size | 48 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Japan clinical trial assosiation | ||||||
| Division name | N.A. | ||||||
| Zip code | 1600022 | ||||||
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo | ||||||
| TEL | 0364574666 | ||||||
| info@yakujihou.org | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japan clinical trial assosiation | ||||||
| Division name | N.A. | ||||||
| Zip code | 1600022 | ||||||
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo | ||||||
| TEL | 0364574666 | ||||||
| Homepage URL | |||||||
| info@yakujihou.org | |||||||
| Sponsor | |
| Institute | Japan clinical trial assosiation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | EC STUDIO Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Pharmaceutical Law Wisdoms |
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo |
| Tel | 0364574911 |
| master@yakujihou.net | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 51 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043091 |